Phage Display Platform News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Phage display platform. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Phage Display Platform Today - Breaking & Trending Today

Boan Biotech Announces 2022 Financial Results, Showing Accelerated Innovation and Strong 225% Revenue Growth

YANTAI, CHINA - Media OutReach - 28 March 2023 - Boan Biotech (6955.HK) announced its 2022 financial results and recent business developments on March 27, 2023. 2022 business. ....

Hong Kong , Jiang Hua , Sino Biopharm , Phage Display Technology Platform , National Reimbursement Drug List , Bispecific Engager Technology Platform , Technology Platform , Boan Biotech , Biological License Application , Main Board , Hong Kong Stock Exchange , Shanghai Hong Kong Stock Connect , Shenzhen Hong Kong Stock Connect , Reimbursement Drug List , Human Antibody Transgenic Mouse , Phage Display Platform , Bispecifict Cell Engager Platform , Antibody Drug Conjugate , Chief Executive Officer , Bispecifict Cell Engager Technology Platform ,

Boan Biotech Announces 2022 Financial Results

Showing accelerated innovation and strong 225% revenue growth YANTAI, China, March 27, 2023 /PRNewswire/ Boan Biotech (6955.HK) today announced its 2022 financial results and recent business developments. 2022 business highlights Eye-catching performance of two marketed products Boan Biotech's first drug Boyounuo (bevacizumab injection, a biosimilar to Avastin®) is used for the treatment of multiple cancers. Sales grew rapidly. ....

Jiang Hua , Hong Kong , Sino Biopharm , National Reimbursement Drug List , Boan Biotech , Biological License Application , Main Board , Hong Kong Stock Exchange , Shanghai Hong Kong Stock Connect , Shenzhen Hong Kong Stock Connect , Reimbursement Drug List , Human Antibody Transgenic Mouse , Phage Display Platform , Bispecifict Cell Engager Platform , Antibody Drug Conjugate , Chief Executive Officer ,